Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Acute Care Syndromic Testing Market Poised To Hit $8.3 Billion By 2030 With A 12.5% CAGR#_x000D_
The acute care syndromic testing market has seen rapid growth in recent years. This market is projected to expand from $4.59 billion in 2025 to $5.17 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.8%. Historically, the expansion of this market can be attributed to the demand for emergency infection diagnosis, the enlargement of hospital intensive care units, initiatives focused on outbreak preparedness, the increasing adoption of molecular diagnostics, and the streamlining of critical care workflows._x000D_
_x000D_
The acute care syndromic testing market is anticipated to experience significant expansion in the next few years, with its size projected to reach $8.3 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is attributed to several factors including AI-enabled syndromic panels, the expansion of emergency testing, the implementation of antimicrobial stewardship programs, the development of point-of-care molecular systems, and a heightened focus on pandemic preparedness. Noteworthy trends for the same period encompass rapid multiplex pathogen detection, the integration of molecular testing in emergency departments, the availability of single-sample multi-disease panels, advancements in faster clinical decision support, and a reduction in diagnostic turnaround time._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Acute Care Syndromic Testing Market Growth Factors: What’s Supporting Expansion?#_x000D_
The increasing prevalence of infectious diseases is projected to drive the acute care syndromic testing market forward. These illnesses are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites and can spread among people, animals, or from the environment. The rising incidence of infectious diseases is influenced by factors like population growth, urbanization, global travel, antimicrobial resistance, and climate change, thereby escalating the demand for effective prevention and treatment. Acute care syndromic testing is utilized in infectious diseases for the rapid identification of pathogens and co-infections via multiplex molecular diagnostics, enabling precise treatment decisions. For instance, in February 2024, according to the Health Security Agency, a UK-based government agency, in week 4 of 2024, the influenza positivity rate saw an increase to 16.6% from 14.0% in the preceding week. Consultations for influenza-like illness (ILI) also climbed to 9.8 per 100,000 people, up from 7.5 per 100,000 in the week prior. Additionally, influenza hospitalizations rose to 7.63 per 100,000, an increase from 5.12 per 100,000 the week before. Thus, the growing occurrence of infectious diseases is a key driver for the acute care syndromic testing market._x000D_
_x000D_
#Acute Care Syndromic Testing Market Segment Landscape: Which Areas Lead Development?#_x000D_
The acute care syndromic testing market covered in this report is segmented – _x000D_
_x000D_
1) By Disease Type: Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types_x000D_
2) By Sample Type: Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types_x000D_
3) By Target: Bacteria, Viruses, Fungi, Parasites_x000D_
4) By End User: Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Respiratory Diseases: Influenza, Respiratory Syncytial Virus (RSV), COVID-19, Tuberculosis, Other Respiratory Diseases _x000D_
2) By Gastrointestinal Diseases: Clostridium Difficile Infection, Norovirus, Rotavirus, Salmonella, Other Gastrointestinal Diseases _x000D_
3) By Genitourinary Diseases: Urinary Tract Infections (UTIs), Sexually Transmitted Infections (STIs), Vaginal Infections, Other Genitourinary Diseases _x000D_
4) By Tropical Diseases: Malaria, Dengue, Chikungunya, Zika Virus, Other Tropical Diseases _x000D_
5) By Other Disease Types: Meningitis, Sepsis, Other Emerging Infectious Diseases_x000D_
_x000D_
#Acute Care Syndromic Testing Market Industry Trends: What’s Reshaping Demand?#_x000D_
Companies active in the acute care syndromic testing market are increasingly concentrating on technological progress, specifically multiplex real-time polymerase chain reaction (PCR) technology, to elevate diagnostic accuracy, facilitate quick pathogen detection, optimize laboratory workflows, shorten turnaround times, and enhance patient outcomes through accurate and prompt treatment. This advanced molecular diagnostic technique, multiplex real-time PCR, enables the concurrent detection and quantification of numerous pathogens or genetic targets within a single PCR reaction, thereby boosting the efficiency and precision of disease diagnosis. For example, in April 2023, QIAGEN N.V., a Netherlands-based biotechnology research company, introduced its QIAstat-Dx syndromic testing solution in Japan. This solution features a SARS-CoV-2 respiratory panel designed to detect over 20 pathogens from a single sample. By employing multiplex real-time PCR technology, it yields rapid results with significantly less labor compared to individual PCR assays. The system is accessible in over 100 countries, consequently broadening the global reach of syndromic testing._x000D_
_x000D_
#Acute Care Syndromic Testing Market Competitive Analysis Of Leading Industry Participants#_x000D_
Major companies operating in the acute care syndromic testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Seegene Inc., bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc. _x000D_
_x000D_
#View The Full Acute Care Syndromic Testing Market Report:#_x000D_
_x000D_
#Acute Care Syndromic Testing Market Geographic Distribution And Regional Opportunities#_x000D_
North America was the largest region in the acute care syndromic testing market in 2025. The regions covered in the acute care syndromic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
